Agomelatine: a novel antidepressant.

  title={Agomelatine: a novel antidepressant.},
  author={Randy A. Sansone and Lori A. Sansone},
  journal={Innovations in clinical neuroscience},
  volume={8 11},
Depression is highly prevalent in community and primary care samples. According to the findings of the Sequential Treatment Alternatives to Relieve Depression study, after multiple clinical interventions, approximately one-third of patients never fully experienced remission from depression. This somber finding invites consideration of novel antidepressant options, which may in the near future include agomelatine. Agomelatine is a melatonergic agonist and a 5HT(2c) antagonist (i.e., it has a… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
16 Citations
0 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 16 extracted citations

Similar Papers

Loading similar papers…